Dr. Roy Herbst
Medical Oncology · Houston, TX
CMS Profile ID: 73386 · NPI: 1619060498
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$586,664
Number of Payments
125
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Honoraria | $400,000 |
| Consulting Fee | $117,048 |
| Travel and Lodging | $58,039 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,800 |
| Food and Beverage | $2,777 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Immunocore Limited | $496,768 |
| Merck Sharp & Dohme LLC | $32,277 |
| Regeneron Pharmaceuticals, Inc. | $21,351 |
| F. Hoffmann-La Roche AG | $14,241 |
| AstraZeneca Pharmaceuticals LP | $9,885 |
| Dr.Reddy's Laboratories,Inc. | $3,000 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?